Market Update (NYSE:MRK): Merck Announces that IMPROVE-IT Achieved Primary Endpoint; Data to be Presented at American Heart Association Scientific Sessions Today

[Business Wire] – Merck , known as MSD outside the United States and Canada, today said that IMPROVE-IT met its primary endpoint. The results are scheduled to be presented at the American Heart . . . → Read More: Market Update (NYSE:MRK): Merck Announces that IMPROVE-IT Achieved Primary Endpoint; Data to be Presented at American Heart Association Scientific Sessions Today Similar Articles: Stock Update (NYSE:MRK): Merck Congratulates Ecuador as Second Country to Receive PAHO/WHO Verification of Elimination of River Blindness Company Update: Merck & Co Inc (NYSE:MRK) – Merck Completes Sale of Consumer Care Business to Bayer AG for $14.2 Billion Company Update (NYSE:MRK): Merck Announces Third-Quarter 2014 Dividend